The most common comorbidities among Covid-19 patients are hypertension and diabetes mellitus. To prevent chonic diseases such as hypertension and diabetes mellitus, the government through BPJS Kesehatan manage a chronic disease management programs (Program pengelolaan penyakit krnonis-Prolanis). The pandemic has impacted all aspects including Prolanis activities. This study aims to find out the differences between input, process, and output of the Prolanis before and during the Covid-19 pandemic at the Temanggung public health center. The research used qualitative research. The informants in this study consisted of Prolanis management officers, Prolanis participants who suffered from hypertension, and type 2 diabetes mellitus. Data was collected through in-depth interviews, observations, and secondary data. The results of this study explained there were differences on input categories (money and material), all process categories (planning, organizing, actuating, controlling), and output of the indicators for visiting participants. Meanwhile, for the input categories of man, machine, and method as well as the output of the the controlled Prolanis participant ratio (Rasio Peserta Prolanis Terkendali-RPPT) indicator there was no difference compared to before and during the pandemic. This research recommended for health workers to increase their role as educators to promote the importance of joining Prolanis, so the participants are motivated to make regular visits both during and after the pandemic.

COVID-19 masalah kesehatan serius yang perlu terus dipantau dan perlu penanganan khusus. Pemutusan rantai penularan COVID-19 dengan mematuhi protocol kesehatan seperti menggunakan masker, dan menjaga jarak serta melakukan vaksinasi. Pemerintah telah menerapkan kebijakan vaksinasi untuk meningkatkan kekebalan tubuh pada masyarakat dan menekan penyebaran virus COVID-19 yang menghambat perekonomian. Kota Semarang, mendapat apresiasi presiden terkait angka vaksinasi yang tinggi. Prosentase capaian vaksinasi dosis pertama sebesar 124.36% dan dosis kedua sebanyak 112.30% dari target provinsi Jawa Tengah (Kementerian Kesehatan, 2022). Prosentase capaian yang tinggi didukung dengan inovasi pendataan vaksinasi berbasis website, Vaksinasi COVID-19 Kota Semarang Terintegrasi (VICTORI). Namun kajian keberhasilan pelaksanaan vaksinasi maupun kemudahan penggunaan website VICTORI di Kota Semarang belum tersedia, sehingga khalayak luas belum dapat mengetahui maupun membelajari keberhasilan ini. Kajian evaluasi pelaksanaan vaksinasi COVID-19 di Kota Semarang perlu dilakukan dari segi literatur maupun kenyataan pelaksanaan di lapangan. Tujuan utamanya untuk Continuous Quality Improvement, mengingat pelaksanaan vaksinasi dosis ketiga dan keempat terus berlanjut, serta harapannya dapat menarik masyarakat secara sadar diri untuk melakukan vaksin sehingga tercapai prosentase capaian vaksinasi yang tinggi dan masyarakat lebih terlindungi dari penyebaran COVID-19.